Skip to main content
. 2022 Sep 2;10(9):1448. doi: 10.3390/vaccines10091448
GBM Glioblastoma
WHO World Health Organization
OXPHOS Oxidative phosphorylation
TMZ Temozolomide
BBB Blood-brain barrier
5hmC 5-hydroxymethylcytosine
IDH1 Isocitrate dehydrogenase 1
PDGFRA Platelet-Derived Growth Factor Receptor Alpha
ACVR1 Activin A receptor type I
HDACs Histone deacetylases
HATs Acetyltransferases
DNMTi DNA methylation inhibitors
PBMC Peripheral blood mononuclear cells
PFS6 Progression-free survival
VPA Valproic acid
EMT Epithelial-mesenchymal transition
BRD Bromodomain
IDO Indolamine 2,3-dioxygenase
BsAbs Bispecific antibodies
TAAs Tumor-associated antigens
ADCC Antibody-dependent cytotoxicity
PRRs Pattern recognition receptors
HSV-TK Herpes simplex virus type 1
DCVs Dendritic cell vaccines